Using combined oral contraceptives may decrease risk of Ovarian, Endometrial and Colorectal cancer
Using combined oral contraceptives may decrease risk of Ovarian, Endometrial and Colorectal cancer
Isatuximab + Kd in RRMM: Depth of Response Results From the IKEMA Trial
War in Ukraine: Global cancer aid to support refugees
War in Ukraine: The International Brain Tumour Alliance's response to aiding refugees during the crisis
Ibrutinib plus venetoclax for 1-L treatment of CLL and small lymphocytic lymphoma shows a clinically meaningful PFS
Rucaparib effective as maintenance therapy following first-line platinum-based chemo in ovarian cancer
RAGNAR study evidences efficacy and safety of erdafitinib in patients with advanced FGFR+ malignancies
ASCO and WHO to collaborate on quality indicators for cancer facilities
CAR-T cell therapy targeting BCMA is highly effective for patients with relapsed/refractory multiple myeloma
Treatment with high-dose multi-agent chemotherapy for high-risk lymphoma is effective but with significant toxicity
Comment: Addition of ixazomib to pomalidomide and dexamethasone improves survival for multiple myeloma patients
EHA update: Lenalidomide, bortezomib, and dexamethasone ASCT to progress for NDMM